This arose because whilst PAI-1 levels are found to be higher in stroke than in controls, the 5G5G genotype – that itself is associated with elevated stroke risk relative to 4G4G - was associated with a ∼25% reduction in PAI-1 levels relative to 4G4G. The gene discussed is SERPINE1; the disease is stroke disorder.